Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods
about
Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rodsEffect of pH on in vitro antimicrobial susceptibility of the Bacteroides fragilis group.Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.Synergistic efficacy of Bisbenzimidazole and Carbonyl Cyanide 3-Chlorophenylhydrazone combination against MDR bacterial strains.In vitro properties of designed antimicrobial peptides that exhibit potent antipneumococcal activity and produces synergism in combination with penicillin.Activities of clinafloxacin, alone and in combination with other compounds, against 45 gram-positive and -negative organisms for which clinafloxacin MICs are high.Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.Mechanisms of action and in vivo antibacterial efficacy assessment of five novel hybrid peptides derived from Indolicidin and Ranalexin against Streptococcus pneumoniae.
P2860
Q33690784-1AE05430-7547-4D1C-B64A-B71480C2BAFBQ33692980-DEBD05E8-AD76-412A-AC4F-07B28DBC05ECQ35136059-158C995F-F6F2-4089-AA90-E4F3FCF64AD6Q35137076-10E5DE2D-C076-427C-8894-1CC3423A1C52Q35138302-5952A518-3C25-45B9-9E31-984AFF3CA339Q35138311-CF60BC3C-00CE-4598-87BE-EDA9BB1B52B4Q37707919-F4A89DD0-5694-4E6B-953B-FC5F517A46DDQ39005488-1D86BE44-3A54-4A0D-A142-59AEFB13CCB8Q39471785-756CEF53-3CFE-4724-9FCD-B9B4BCF827D4Q39731834-F9A68044-DEAC-44C6-B240-9AD32BE1EB57Q41912214-AC0F7E8B-D9B9-463B-9A5E-767FCC5CC15FQ41949708-234E39BF-FBBA-4CC7-A304-4AB274528DACQ42270753-413CC9AA-A188-4508-A9C3-2AA62E37AE4C
P2860
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Antipneumococcal activities of ...... kerboard and time-kill methods
@ast
Antipneumococcal activities of ...... kerboard and time-kill methods
@en
type
label
Antipneumococcal activities of ...... kerboard and time-kill methods
@ast
Antipneumococcal activities of ...... kerboard and time-kill methods
@en
prefLabel
Antipneumococcal activities of ...... kerboard and time-kill methods
@ast
Antipneumococcal activities of ...... kerboard and time-kill methods
@en
P2093
P2860
P356
P1476
Antipneumococcal activities of ...... kerboard and time-kill methods
@en
P2093
M A Visalli
M R Jacobs
P C Appelbaum
S Bajaksouzian
P2860
P304
P356
10.1128/AAC.40.9.1973
P407
P577
1996-09-01T00:00:00Z